Centrale del Latte d’Italia — Integration progressing

Centrale del Latte d'Italia

Integration progressing

FY16 results

Food & beverages

9 March 2017

Price	€2.89
Market cap	€40m

Net debt (€m) at 31 December 2016		60.23

Shares in issue		14.0m
Free float		41%
Code		CLI

Primary exchange	STAR (Borsa Italiana)
Secondary exchange		N/A

Share price performance

%	1m	3m	12m
Abs	2.9	2.9	(4.3)
Rel (local)	(1.0)	(3.3)	(12.0)

52-week high/low

€3.3

€2.6

Business description

Centrale del Latte d'Italia produces and distributes fresh and long-life milk (UHT and ESL), and dairy products such as cream, yoghurt and cheese. It has a leading position in milk in the Piedmont region of northern Italy, and it has expanded to the Veneto, Liguria and Tuscany regions.

Next events

AGM meeting	27 April 2017
Q1 17 results	12 May 2017
H1 17 results	3 August 2017
9m 17 results	10 November 2017

Analysts

Sara Welford	+44 (0) 20 3077 5700
Paul Hickman	+44 (0)20 3681 2501

consumer@edisongroup.com

Edison profile page

Centrale del Latte d'Italia is a research client of Edison Investment Research Limited

The domestic market remains challenging, and raw material prices are now increasing. FY16 revenues were slightly ahead of our forecast and FY17 seems to have got off to a good start. Centrale del Latte d'Italia (CLI) is due to increase its list prices as of 1 April, which should help it offset the cost inflation. The main event of FY16 – the merger between CLT and CLF which gave rise to the new entity CLI – is still being bedded in, and we expect the integration to continue to make progress.

Year end	Revenue (€m)	PBT* (€m)	EPS* (c)	DPS (c)	P/E (x)	Yield (%)
12/15	98.3	0.46	0.30	6.00	N/A	2.1
12/16	119.8	(2.09)	(19.57)	6.00	N/A	2.1
12/17e	177.5	0.54	3.95	6.00	73.1	2.1
12/18e	178.4	1.02	7.48	6.00	38.6	2.1

Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments.

Underlying sales up 0.6% but profitability lower

It is hard to benchmark the performance of CLI in FY16 given the merger occurred on 30 September. However in underlying terms, fresh milk and ESL witnessed some growth, while UHT milk and yoghurt declined. Lower prices in bulk milk and cream were also unhelpful, but overall sales progressed 0.6% ex M&A effects. Profitability was lower as there were increased costs associated with brand support and sales functions. In addition, there were increased maintenance costs and costs associated with the merger, so it is hard to gauge the true underlying picture without further guidance regarding the specific merger costs.

Forecasts cut

Valuation: Fair value of €2.85 per share

Our DCF model points to a fair value of €2.85 per share (from €2.83), implying the stock is fairly valued. We have rolled forward our DCF model to commence in 2017, and this offsets the cuts to our forecasts. We calculate that for FY17 CLI now trades at 72.6x P/E and 11.4x EV/EBITDA, with a 2.1% dividend yield. The P/E is inflated due to the relatively elevated debt level in the short term associated with the CLF acquisition, and hence the high interest costs. We expect these to normalise by 2019. On EV/EBITDA, CLI trades at a premium of 11.8% to the average of our peer group of dairy processors.

FY16 results review

Total FY16 revenue of €119.8m was slightly ahead of our forecast of €118.1m. The main event during FY16 was, of course, the merger between CLT (Centrale del Latte di Torino) and CLF (Centrale del Latte di Firenze), which gave rise to the new entity, or CLI. Comparisons with the prior year are therefore harder to make, and naturally management time was mostly dedicated to the merger process.

In underlying terms (excluding the effects of the merger), the trends witnessed during the first nine months of the year continued into Q4. For the FY, therefore, fresh milk and ESL sales experienced some growth, while UHT milk and yoghurt declined. UHT milk sales were down due to continued aggressive promotional activity by the competition, in which CLI chose not to participate.

FY17 has got off to a good start, with the first two months of the year seeing encouraging growth across the board. Milk prices have started to rise and CLI has announced that as of 1 April it will be raising its list prices to its customers, which should help the company offset some of the rising raw material costs.

EBITDA of €2.91m in FY16 compares with €4.85m in FY15. Profitability suffered due to a number of factors, including:

■

Increased (one-off) costs (of c €0.4 m) associated with expanding and supporting CLI’s brands in new areas that are adjacent to its existing geographies of strength. This has involved a ramp-up in marketing costs and in sales and distribution costs. These will be absorbed through operating leverage once the business has expanded, but obviously remained relatively high in the ramp-up phase.

■

Increased administration costs associated with the CLF merger (of c €1 m).

■

Increased costs of brand support in general.

■

One-off maintenance costs to improve efficiencies.

Financials

Pro-forma sales for FY16 had the CLF business been owned for the full 12 months would have been €176m. For FY17 we therefore now forecast 0.8% revenue growth to €177.5m, and 0.6% revenue CAGR in 2016-19e. We expect EBITDA margin improvement in FY17 due to the positive mix effect of the CLF business (CLF’s business had EBIT margins of 3.4% in 2014 vs CLT’s 2.7%). We forecast 4.6% EBITDA CAGR 2017e-19e, with margin then settling at our 3% terminal EBIT margin assumption (see our DCF valuation section below).

We have trimmed our FY17-19e revenue growth assumptions as deflation continues to feature in the domestic Italian market. The comparatively high operating leverage in the business means the cut to EBITDA is sharper at c 20%. The relatively elevated level of debt in the short term associated with the CLF merger mean the fixed cost leverage is high, and thus cuts are amplified further down the P&L, and our adjusted PBT forecasts fall by 70-80%. Due to the nature of the business, however, any positive surprises at the revenue and EBITDA level should translate into much greater upgrades further down the P&L. Any recovery in the domestic Italian economy should be positive for consumer spending and could drive forecasts higher. We note the depreciation levels are high, reflecting a well-invested asset base, hence the management should be able to fully focus on debt reduction over the next few years.

Valuation

CLI’s share price has increased 3.2% over the last three months vs the FTSE MIB, which is up 14.2%. It has also underperformed relative to the FTSE MIB on a six- and 12-month basis. On 2017 estimates, CLI trades at 72.6x P/E and 11.4x EV/EBITDA, with a 2.1% dividend yield. The P/E is inflated due to the high level of debt following the merger, and hence the high interest costs. These contribute to a squeeze on earnings. We expect EBITDA growth to return in FY17 and forecast steady improvement through to FY19. The leverage in the business means we expect earnings to return to a more normal level by FY19. On EV/EBITDA, CLI trades at a premium of 11.8% to the average of our peer group of dairy processors (although we note the peer group companies are much larger than CLI).

Exhibit 1: Benchmark valuation of CLI relative to peers

	Market cap (m)	P/E (x)		EV/EBITDA (x)		Dividend yield (%)
	Market cap (m)	2017e	2018e	2017e	2018e	2017e	2018e
Parmalat	€5,342.8	30.0	32.0	9.7	8.5	0.7	0.7
Dairy Crest	£785.8	15.6	14.4	11.6	10.7	4.1	4.2
Dean Foods	$1,672.7	12.8	12.2	5.5	5.2	2.1	2.2
Saputo	$17,955.7	24.3	22.0	14.1	12.8	1.3	1.4
Peer group average		20.7	20.1	10.2	9.3	2.0	2.1
CLI	€39.9	72.6	38.4	11.4	10.9	2.1	2.1

Premium/(discount) to peer group (%)		250.7	91.0	11.8	17.2	3.4	-1.8

Source: Edison Investment Research estimates and Bloomberg consensus. Note: Prices at 6 March 2017.

We use DCF analysis to value the shares and calculate a fair value of €2.85 (previously €2.83), implying the stock is fairly valued. We have assumed no cost synergies from the merger, which is in line with company guidance. We have also rolled forward our DCF to commence in 2017.

Our DCF is based on our assumptions of 1.5% terminal growth rate and 3% terminal EBIT margin. Our WACC of 5.8% is based on an equity risk premium of 4.5%, a borrowing spread of 5% and beta of 0.9. Below, we show a sensitivity analysis to these assumptions and note that the current share price is discounting a terminal EBIT margin of 3.1% (which compares to CLT’s reported EBIT margin of 2.7% in 2014 and 1.6% in 2015) with a terminal growth rate of c 1.5%.

Exhibit 2: DCF sensitivity (€/share) to terminal growth rate and EBIT margin

		Terminal EBIT margin
		2.00%	2.50%	3.00%	3.50%	4.00%	4.50%
Terminal growth	0.00%	0.80	1.28	1.76	2.25	2.73	3.21
	0.50%	0.98	1.51	2.05	2.58	3.11	3.64
	1.00%	1.21	1.80	2.39	2.98	3.57	4.16
	1.50%	1.49	2.15	2.85	3.47	4.13	4.79
	2.00%	1.84	2.59	3.34	4.10	4.85	5.60
	2.50%	2.30	3.17	4.04	4.91	5.77	6.64
	3.00%	2.92	3.95	4.98	6.00	7.03	8.05
	3.50%	3.81	5.07	6.32	7.57	8.82	10.08
	4.00%	5.19	6.79	8.39	10.00	11.60	13.20

Source: Edison Investment Research

Exhibit 3: Financial summary

	€'000s	2013	2014	2015	2016	2017e	2018e	2019e
31-December		IFRS	IFRS	IFRS	IFRS	IFRS	IFRS	IFRS
INCOME STATEMENT
Revenue		99,967.0	102,558.0	98,318.9	119,762.0	177,464.1	178,351.4	179,243.2
Cost of Sales		(80,923.4)	(82,415.2)	(78,796.3)	(98,651.6)	(141,664.9)	(142,194.8)	(142,726.6)
Gross Profit		19,043.7	20,142.8	19,522.6	21,110.4	35,799.2	36,156.6	36,516.6
EBITDA		4,910.6	5,844.8	4,850.6	2,904.7	8,546.8	8,946.2	9,349.5
Normalised operating profit		1,379.1	2,751.7	1,553.8	(1,254.1)	2,682.5	3,165.7	3,984.2
Amortisation of acquired intangibles		0.0	0.0	0.0	0.0	0.0	0.0	0.0
Exceptionals		(249.9)	(134.0)	145.0	(355.0)	0.0	0.0	0.0
Share-based payments		0.0	0.0	0.0	0.0	0.0	0.0	0.0
Reported operating profit		1,129.1	2,617.6	1,698.8	(1,609.1)	2,682.5	3,165.7	3,984.2
Net Interest		(674.5)	(810.7)	(678.0)	(691.7)	(2,002.3)	(2,006.2)	(2,002.0)
Joint ventures & associates (post tax)		(3.9)	(4.2)	(417.6)	(143.2)	(143.2)	(143.2)	(143.2)
Exceptionals		1,646.2	0.0	0.0	13,902.9	0.0	0.0	0.0
Profit Before Tax (norm)		2,346.8	1,936.7	458.2	(2,089.1)	537.0	1,016.2	1,838.9
Profit Before Tax (reported)		2,096.9	1,802.7	603.2	11,458.9	537.0	1,016.2	1,838.9
Reported tax		(827.0)	(1,011.6)	(86.6)	556.0	(187.9)	(355.7)	(643.6)
Profit After Tax (norm)		2,042.5	809.4	30.3	(2,152.8)	553.3	1,047.2	1,895.0
Profit After Tax (reported)		1,269.9	791.1	516.6	12,014.8	349.0	660.5	1,195.3
Minority interests		0.0	0.0	0.0	0.0	0.0	0.0	0.0
Discontinued operations		0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net income (normalised)		2,042.5	809.4	30.3	(2,152.8)	553.3	1,047.2	1,895.0
Net income (reported)		1,269.9	791.1	516.6	12,014.8	349.0	660.5	1,195.3

Basic average number of shares outstanding (m)		10	10	10	11	11	14	14
EPS - basic normalised (€)		0.20	0.08	0.00	(0.20)	0.04	0.07	0.14
EPS - diluted normalised (€)		0.20	0.08	0.00	(0.20)	0.04	0.07	0.14
EPS - basic reported (€)		0.13	0.08	0.05	1.09	0.02	0.05	0.09
Dividend (€)		0.06	0.06	0.06	0.06	0.06	0.06	0.06

Revenue growth (%)		#DIV/0!	2.6	(-4.1)	21.8	48.2	0.5	0.5
Gross Margin (%)		19.0	19.6	19.9	17.6	20.2	20.3	20.4
EBITDA Margin (%)		4.9	5.7	4.9	2.4	4.8	5.0	5.2
Normalised Operating Margin		1.4	2.7	1.6	-1.0	1.5	1.8	2.2

BALANCE SHEET
Fixed Assets		65,063.6	64,184.5	64,540.0	129,772.7	129,409.8	129,336.5	129,527.8
Intangible Assets		11,776.9	11,706.2	11,538.8	19,484.0	19,410.7	19,337.3	19,264.0
Tangible Assets		52,652.3	51,670.9	52,009.6	107,334.8	107,045.2	107,045.2	107,309.8
Investments & other		634.4	807.5	991.7	2,954.0	2,954.0	2,954.0	2,954.0
Current Assets		35,646.7	36,689.3	41,122.1	60,457.3	71,854.4	71,978.8	72,374.1
Stocks		3,473.1	3,437.8	3,540.6	7,697.6	11,053.9	11,095.3	11,136.7
Debtors		16,210.3	15,719.7	14,370.1	28,208.8	42,501.1	42,713.6	42,927.2
Cash & cash equivalents		7,822.1	10,050.8	12,192.4	9,521.0	3,006.9	2,877.4	3,017.6
Other		8,141.3	7,480.9	11,018.9	15,029.9	15,292.6	15,292.6	15,292.6
Current Liabilities		(34,211.0)	(33,231.9)	(35,004.4)	(68,199.0)	(86,908.0)	(87,138.6)	(87,369.8)
Creditors		(23,402.2)	(23,743.5)	(24,246.7)	(42,909.5)	(61,618.6)	(61,849.1)	(62,080.4)
Tax and social security		(333.3)	(467.7)	(356.9)	(697.4)	(697.4)	(697.4)	(697.4)
Short term borrowings		(10,475.4)	(9,020.8)	(10,400.7)	(24,592.0)	(24,592.0)	(24,592.0)	(24,592.0)
Other		0.0	0.0	0.0	0.0	0.0	0.0	0.0
Long Term Liabilities		(25,775.9)	(27,178.1)	(29,847.5)	(58,489.4)	(51,305.5)	(51,305.5)	(51,305.5)
Long term borrowings		(17,297.0)	(18,218.6)	(22,446.0)	(45,158.9)	(45,158.9)	(45,158.9)	(45,158.9)
Other long term liabilities		(8,478.9)	(8,959.5)	(7,401.5)	(13,330.5)	(6,146.6)	(6,146.6)	(6,146.6)
Net Assets		40,723.4	40,463.7	40,810.3	63,541.7	63,050.7	62,871.2	63,226.5
Minority interests		0.0	0.0	0.0	0.0	0.0	0.0	0.0
Shareholders' equity		40,723.4	40,463.7	40,810.3	63,541.7	63,050.7	62,871.2	63,226.5

CASH FLOW
Op Cash Flow before WC and tax		4,910.6	5,844.8	4,850.6	2,904.7	8,546.8	8,946.2	9,349.5
Working capital		1,714.6	1,810.8	(1,942.2)	(30.0)	(2,279.5)	(23.3)	(23.8)
Exceptional & other		31.0	(128.7)	(1,262.2)	(15,092.0)	(143.2)	(143.2)	(143.2)
Tax		(827.0)	(1,011.6)	(86.6)	556.0	(187.9)	(355.7)	(643.6)
Net operating cash flow		5,829.2	6,515.3	1,559.6	(11,661.3)	5,936.1	8,424.0	8,538.8
Capex		(780.5)	(2,107.1)	(3,913.8)	(4,094.6)	(5,501.4)	(5,707.2)	(5,556.5)
Acquisitions/disposals		0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net interest		(674.5)	(810.7)	(678.0)	(691.7)	(2,002.3)	(2,006.2)	(2,002.0)
Equity financing		0.0	0.0	0.0	0.0	0.0	0.0	0.0
Dividends		(200.0)	(600.0)	(600.0)	(600.0)	(840.0)	(840.0)	(840.0)
Other		(5,922.6)	2,293.5	5,031.4	(1,130.7)	0.0	0.0	0.0
Net Cash Flow		(1,748.4)	5,290.9	1,399.1	(18,178.3)	(2,407.6)	(129.5)	140.3
Opening net debt/(cash)		25,676.0	19,950.2	17,188.6	20,654.3	60,230.0	66,744.1	66,873.5
FX		0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other non-cash movements		7,474.2	(2,529.3)	(4,864.8)	(21,397.4)	(4,106.5)	0.0	0.0
Closing net debt/(cash)		19,950.2	17,188.6	20,654.3	60,230.0	66,744.1	66,873.5	66,733.3

Source: Company data, Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting. Edison is authorised and regulated by the Financial Conduct Authority. Edison Investment Research (NZ) Limited (Edison NZ) is the New Zealand subsidiary of Edison. Edison NZ is registered on the New Zealand Financial Service Providers Register (FSP number 247505) and is registered to provide wholesale and/or generic financial adviser services only. Edison Investment Research Inc (Edison US) is the US subsidiary of Edison and is regulated by the Securities and Exchange Commission. Edison Investment Research Limited (Edison Aus) [46085869] is the Australian subsidiary of Edison and is not regulated by the Australian Securities and Investment Commission. Edison Germany is a branch entity of Edison Investment Research Limited [4794244]. www.edisongroup.com

DISCLAIMER
Copyright 2017 Edison Investment Research Limited. All rights reserved. This report has been commissioned by Centrale del Latte d'Italia and prepared and issued by Edison for publication globally. All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report. Opinions contained in this report represent those of the research department of Edison at the time of publication. The securities described in the Investment Research may not be eligible for sale in all jurisdictions or to certain categories of investors. This research is issued in Australia by Edison Aus and any access to it, is intended only for "wholesale clients" within the meaning of the Australian Corporations Act. The Investment Research is distributed in the United States by Edison US to major US institutional investors only. Edison US is registered as an investment adviser with the Securities and Exchange Commission. Edison US relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. As such, Edison does not offer or provide personalised advice. We publish information about companies in which we believe our readers may be interested and this information reflects our sincere opinions. The information that we provide or that is derived from our website is not intended to be, and should not be construed in any manner whatsoever as, personalised advice. Also, our website and the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. This document is provided for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. Edison has a restrictive policy relating to personal dealing. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report. Edison or its affiliates may perform services or solicit business from any of the companies mentioned in this report. The value of securities mentioned in this report can fall as well as rise and are subject to large and sudden swings. In addition it may be difficult or not possible to buy, sell or obtain accurate information about the value of securities mentioned in this report. Past performance is not necessarily a guide to future performance. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (ie without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision. To the maximum extent permitted by law, Edison, its affiliates and contractors, and their respective directors, officers and employees will not be liable for any loss or damage arising as a result of reliance being placed on any of the information contained in this report and do not guarantee the returns on investments in the products discussed in this publication. FTSE International Limited (“FTSE”) © FTSE 2017. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

245 Park Avenue, 39th Floor

10167, New York

Sydney +61 (0)2 8249 8342

Level 12, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

245 Park Avenue, 39th Floor

10167, New York

Sydney +61 (0)2 8249 8342

Level 12, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

245 Park Avenue, 39th Floor

10167, New York

Sydney +61 (0)2 8249 8342

Level 12, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

245 Park Avenue, 39th Floor

10167, New York

Sydney +61 (0)2 8249 8342

Level 12, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Equities

Equities by Sector

Sectors

Thematics

Latest

Healthcare-focused trusts: A sector on the mend

MediaWatch – One step forward, two steps back

ConsumerWatch – Don’t look down

Audiovisual

Latest

Recce Pharmaceuticals – executive interview

VEON – executive interview with CFO Joop Brakenhoff

VEON – executive interview with CEO Kaan Terzioğlu

About Edison

About Edison

Careers

Centrale del Latte d’Italia — Integration progressing

Latest

Games Workshop Group — A notable acceleration in Q225

Altron — Further margin expansion in H125

Sayona Mining — Catching up with majors

ProCredit Holding — Management expects ROE of c 10% in FY24

Avon Technologies — Record order book driving confident outlook

PPHE Hotel Group — Up for the challenge

Subscribe to Edison